Mianzhu Chengxin Pharmaceutical Glass Factory was established in August 1988 and was restructured into Sichuan Mianzhu Chengxin Pharmaceutical Glass Co., Ltd. in 2004. Since June 2016, it has been wholly-owned by Shandong Pharmaceutical Glass Co., Ltd. and is now a wholly-owned subsidiary of Shandong Pharmaceutical Glass Co., Ltd. Sichuan Mianzhu Chengxin Pharmaceutical Glass Co., Ltd. covers an area of 141,000 square meters, has a registered capital of RMB 200 million, and has more than 460 employees. It is mainly engaged in the production and sales of soda-lime glass moulded injection vials, soda-lime glass infusion bottles, soda-lime glass moulded pharmaceutical bottles, soda-lime glass tubular oral liquid bottles, low borosilicate glass tubular injection vials, low borosilicate glass tubular oral liquid bottles, brown soda-lime glass moulded pharmaceutical bottles and glass products. At present, Chengxin Pharmaceutical Glass has a total of 8 brown bottle production lines with an annual output of 1 billion brown bottles; 4 clear bottle production lines with an annual output of 800 million clear moulded bottles and infusion bottles; and 16 tubular bottle production lines with an annual output of 170 million tubular bottles. Its annual tax-inclusive output value reaches RMB 350 million, with a profit of RMB 50 million. Relying on the technology and quality control requirements of its headquarters, Shandong Pharmaceutical Glass Co., Ltd., Chengxin Pharmaceutical Glass adopts more advanced processes and production equipment, bringing its product quality to a higher level. The company has passed the ISO9001:2015 quality management system certification and, together with the establishment of procedural documents and standardized systems, provides a reliable guarantee for product quality. Guided by the market, surviving on quality and developing through management, the company has carried out ISO9001 quality management system and ISO14001 environmental management system certification in depth, forming a complete and rigorous quality assurance system internally. From raw material intake to product release, inspections are carried out at every level: unqualified raw materials are not used, unqualified semi-finished products do not enter the next process, and unqualified products are never allowed to leave the factory. Following the corporate guideline of "operating in accordance with the law and standardizing management", and supported by Shandong Pharmaceutical Glass' advanced R&D capability, rich technical strength, strong financial resources, well-known brand influence and 80% national market share, Chengxin Pharmaceutical Glass makes full use of its regional advantages, labor advantages and power and natural gas resource advantages. Based in southwest China and radiating out to southern and southeastern China, the company is committed to building itself into the largest-scale, most complete-variety and best-quality pharmaceutical packaging material production base in southwest China.
Sichuan Mianzhu Chengxin Pharmaceutical Glass Co., Ltd.Mianzhu Chengxin Pharmaceutical Glass Factory was established in August 1988 and was restructured into Sichuan Mianzhu Chengxin Pharmaceutical Glass Co., Ltd. in 2004. Since June 2016, it has been wholly-owned by Shandong Pharmaceutical Glass Co., Ltd. and is now a wholly-owned subsidiary of Shandong Pharmaceutical Glass Co., Ltd. Sichuan Mianzhu Chengxin Pharmaceutical Glass Co., Ltd. covers an area of 141,000 square meters, has a registered capital of RMB 200 million, and has more than 460 employees. It is mainly engaged in the production and sales of soda-lime glass moulded injection vials, soda-lime glass infusion bottles, soda-lime glass moulded pharmaceutical bottles, soda-lime glass tubular oral liquid bottles, low borosilicate glass tubular injection vials, low borosilicate glass tubular oral liquid bottles, brown soda-lime glass moulded pharmaceutical bottles and glass products.At present, Chengxin Pharmaceutical Glass has a total of 8 brown bottle production lines with an annual output of 1 billion brown bottles; 4 clear bottle production lines with an annual output of 800 million clear moulded bottles and infusion bottles; and 16 tubular bottle production lines with an annual output of 170 million tubular bottles. Its annual tax-inclusive output value reaches RMB 350 million, with a profit of RMB 50 million.Relying on the technology and quality control requirements of its headquarters, Shandong Pharmaceutical Glass Co., Ltd., Chengxin Pharmaceutical Glass adopts more advanced processes and production equipment, bringing its product quality to a higher level. The company has passed the ISO9001:2015 quality management system certification and, together with the establishment of procedural documents and standard systems, provides a reliable guarantee for product quality.Guided by the market and surviving on quality, the company seeks development through management
